Executive Director, Regulatory & Medical Affairs

Annette offers consultancy services on regulatory, medical affairs and clinical research of pharmaceutical products and medical devices in HK, Macau and Greater Bay Area.
She is an UK trained pharmacist and a registered pharmacist in Hong Kong. Annette has more than 30 years of experience in the Hong Kong & China pharmaceutical markets. She has successfully led and expedited registrations of more than 20 New Chemical Entities/Biologicals/Vaccines and has obtained numerous product line extension approvals for GlaxoSmithKline (GSK) from 1992 to 2024. She has also extensive RA and PV audit experience and supported a vaccine’s GMP site audit conducted by China CFDI in 2022.
Annette has broad product portfolio exposure which includes oncology, hepatology, GI, respiratory, cardiology, endocrinology, immunology, infectious diseases and vaccines.